While this association had not been previously assessed in JIA, Chou et al. [38] showed that patients with RA treated with anti-TNF agents (infliximab, etanercept, and adalimumab) had a lower risk of cognitive impairment. Here, TNF is linked to juvenile idiopathic arthritis.